# US 2016/0325097 A1 · System for Determination and Utilization of Cardiac Electrical Asynchrony Data

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0325097 A1
- Document ID: US20160325097A1
- Status: Published application
- Kind: A1
- Application number: 15/213,254
- Filed: 2016-07-18
- Published: 2016-11-10
- Earliest claimed: 2012-10-02
- Assignees: XSynchro, Inc.
- Applicants: XSynchro, Inc.
- Inventors: Daniel Felipe Ortega; Julio César Spinelli; Maria Paula Bonomini; Luis Dante Barja
- Web page: https://patentgrep.com/patent/US20160325097A1

## CPC

- A61N 1/3684: {for stimulating the heart at multiple sites of the ventricle or the atrium}
- A61B 5/341: Vectorcardiography [VCG]
- A61B 5/346: Analysis of electrocardiograms
- A61B 5/352: Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
- A61B 5/366: Detecting abnormal QRS complex, e.g. widening
- A61N 1/056: {Transvascular endocardial electrode systems}
- A61N 1/36514: {controlled by a physiological quantity other than heart potential, e.g. blood pressure (controlled by two or more physical parameters A61N1/36585)}
- A61N 1/36542: {controlled by body motion, e.g. acceleration}
- A61N 1/36564: {controlled by blood pressure}
- A61N 1/36585: {controlled by two or more physical parameters}
- A61N 1/3682: {with a variable atrioventricular delay}
- A61N 1/36842: {Multi-site stimulation in the same chamber}
- A61N 1/36843: {Bi-ventricular stimulation}
- A61N 1/3688: {configured for switching the pacing mode, e.g. from AAI to DDD}
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61N 1/37254: {Pacemaker or defibrillator security, e.g. to prevent or inhibit programming alterations by hackers or unauthorised individuals}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

One embodiment provides a system for determination and utilization of cardiac electrical asynchrony data. The system includes an analysis circuitry including a processor and a memory, the analysis circuitry configured to: obtain a plurality of sets of cardiac signals collected in at least two locations of a heart of a patient, the signals comprising at least one of surface electrocardiography signals and pseudo-surface ECG signals; detect one or more QRS complexes for each of the sets based on the cardiac signals for that set; obtain one or more cross-correlation signals, each of the cross-correlation signals being between at least two of the signal sets and being obtained using the detected QRS complexes from the signal sets; and calculate one or more asynchrony indices using one or more of the cross-correlation signals, each of the asynchrony indices being indicative of a level of asynchrony between the at least two locations.

## Claims

### Claim 1

A system for determination and utilization of cardiac electrical asynchrony data, comprising:
an analysis circuitry comprising a processor and a memory, the processor configured to execute computer-executable code stored in the memory, the analysis circuitry configured to:
obtain a plurality of sets of cardiac signals collected in at least two locations of a heart of a patient, the signals comprising at least one of surface electrocardiography signals and pseudo-surface ECG signals;
detect one or more QRS complexes for each of the sets based on the cardiac signals for that set;
obtain one or more cross-correlation signals, each of the cross-correlation signals being between at least two of the signal sets and being obtained using the detected QRS complexes from the at least two signal sets; and
calculate one or more asynchrony indices using one or more of the cross-correlation signals, each of the asynchrony indices being indicative of a level of asynchrony between the at least two locations.

### Claim 2 (depends on 1)

A system according to claim 1, further comprising:
an implantable stimulation device configured to apply stimulation to the patient's heart and to collect two or more of the sets of the cardiac signals while applying the stimulation.

### Claim 3 (depends on 2)

A system according to claim 2, wherein one of:
the analysis circuitry is comprised within the implantable stimulation device; and
the implantable stimulation device wirelessly provides the at least two sets and the intervals to the analysis circuitry via a wireless circuit interfaced to the analysis circuitry.

### Claim 4 (depends on 1)

A system according to claim 1, further comprising:
an implantable stimulation device configured to cycle through a plurality of interventricular (VV) delay intervals inside a pre-determined safety range while applying stimulation to the patient's heart,
wherein the analysis circuitry, for each of the VV delay intervals, calculates one of the asynchrony indices based on the sets of the signals associated with the stimulation applied in accordance with that interval, and determines the VV delay interval associated with a lowest one of the determined asynchrony indices as the optimal VV delay interval.

### Claim 5 (depends on 4)

A system according to claim 4, wherein the stimulation comprises VVI pacing and cycling through the VV delay intervals comprises changing the stimulation in a plurality of steps from right ventricular (RV) only pacing to left ventricular (LV) pacing and one of the steps comprises applying simultaneous biventricular pacing, and the asynchrony index is calculated for the VV delay during each of the steps.

### Claim 6 (depends on 4)

A system according to claim 4, wherein two of the VV delays have the lowest one of the asynchrony indices, and the analysis circuitry is further configured to:
determine a width of an ensemble averaged QRS waveform (AAQRSC) for each of the two VV delays with the lowest asynchrony index; and
set the VV interval with a narrowest one of the AAQRSC as the optimal VV delay interval.

### Claim 7 (depends on 1)

A system according to claim 1, further comprising:
an implantable stimulation device configured to cycle through a plurality of atrioventricular (AV) delay intervals while applying stimulation to the patient's heart in an accordance with a constant interventricular delay interval;
an arterial pulse pressure sensor configured to measure arterial pulse pressure of the subject; and
the analysis circuitry further configured to determine one of the AV delays as the optimal AV delay based on the arterial pulse pressure measured during the application of the stimulation in accordance with that interval.

### Claim 8 (depends on 7)

A system according to claim 7, wherein the arterial pulse pressure is measured over a number of heart beats during the application of the stimulation in accordance with each of the AV intervals and the analysis circuitry is further configured to average the arterial pulse pressure for each of the intervals over the number of the beats, and the averaged pulse pressure is used for the determination of the optimal AV delay.

### Claim 9 (depends on 8)

A system according to claim 8, wherein the number of the beats is defined based on user input.

### Claim 10 (depends on 8)

A system according to claim 8, wherein the number of the beats comprises 8 to 64.

### Claim 11 (depends on 7)

A system according to claim 7, wherein the analysis circuitry is further configured to average the arterial pulse pressure associated with each of the AV intervals over a number of respiratory cycles, and the averaged pulse pressure is used for the determination of the optimal AV delay.

### Claim 12 (depends on 11)

A system according to claim 11, further comprising:
a pulse sensor configured to monitor pulse rate and pulse amplitude of the patient;
the analysis circuitry further configured to detect the respiratory cycles based on a modulation in the pulse rate and the pulse amplitude measured by the pulse sensor.

### Claim 13 (depends on 7)

A system according to claim 7, wherein the stimulation comprises VDD and DDD pacing.

### Claim 14 (depends on 1)

A system according to claim 1, further comprising:
an implantable stimulation device configured to apply stimulation to the patient's heart in accordance with a plurality of AV delays and a plurality of VV delays;
an activity sensor configured to measure a level of activity of the patient during the application of the stimulation by the implantable stimulation device in accordance with one or more of the cycled-through intervals; and
the analysis circuitry further configured to identify an optimal one of the AV delay intervals and the VV delay intervals for each of the activity levels.

### Claim 15 (depends on 14)

A system according to claim 14, wherein the activity sensor comprises at least one of a minute ventilation sensor and an accelerometer.

### Claim 16 (depends on 14)

A system according to claim 14, wherein the implantable device is further configured to apply the stimulation to the patient's heart in accordance with the optimal AV interval and the optimal VV intervals determined for each of the activity levels.

### Claim 17 (depends on 1)

A system according to claim 1, further comprising:
an implantable stimulation device configured to apply stimulation to the patient's heart in accordance with a plurality of AV delays and a plurality of VV delays;
a heart rate sensor configured to measure a heart rate of the patient during the application of the stimulation by the implantable stimulation device in accordance with one or more of the cycled-through intervals;
the analysis circuitry further configured to:
define one or more ranges of the measured heart rate;
identify an optimal one of the AV delay intervals and an optimal one of the VV delay intervals for each of the activity levels.

### Claim 18 (depends on 17)

A system according to claim 17, wherein the heart rate sensor comprises a sinus rate sensor.

### Claim 19 (depends on 17)

A system according to claim 17, wherein the implantable device is further configured to apply the stimulation to the patient's heart in accordance with the optimal AV interval and the optimal VV intervals determined for each of the heart rate ranges.

### Claim 20 (depends on 1)

A system according to claim 1, wherein the cardiac signals are collected using two or more electrocardiographic leads.
